Sumitomo Mitsui Trust Holdings, Inc. Veracyte, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

  • $145 Billion
  • Q4 2024

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,493,377 shares of VCYT stock, worth $75.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,493,377
Previous 2,752,383 9.41%
Holding current value
$75.1 Million
Previous $93.7 Million 5.42%
% of portfolio
0.07%
Previous 0.07%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025
SELL
$31.92 - $44.4 $8.27 Million - $11.5 Million
-259,006 Reduced 9.41%
2,493,377 $98.7 Million
Q3 2024

Nov 05, 2024
SELL
$21.0 - $35.25 $9.01 Million - $15.1 Million
-429,209 Reduced 13.49%
2,752,383 $93.7 Million
Q2 2024

Jul 19, 2024
SELL
$18.86 - $23.55 $3.13 Million - $3.91 Million
-165,844 Reduced 4.95%
3,181,592 $68.9 Million
Q1 2024

Apr 19, 2024
BUY
$21.0 - $29.1 $5.1 Million - $7.06 Million
242,760 Added 7.82%
3,347,436 $74.2 Million
Q4 2023

Jan 30, 2024
SELL
$19.72 - $28.68 $1.36 Million - $1.98 Million
-68,900 Reduced 2.17%
3,104,676 $85.4 Million
Q3 2023

Oct 30, 2023
SELL
$22.33 - $29.92 $1.68 Million - $2.26 Million
-75,437 Reduced 2.32%
3,173,576 $70.9 Million
Q2 2023

Jul 31, 2023
SELL
$20.96 - $26.99 $966,318 - $1.24 Million
-46,103 Reduced 1.4%
3,249,013 $82.8 Million
Q1 2023

Apr 27, 2023
BUY
$20.58 - $27.89 $4.75 Million - $6.43 Million
230,671 Added 7.53%
3,295,116 $73.5 Million
Q4 2022

Jan 30, 2023
BUY
$15.31 - $29.94 $926,668 - $1.81 Million
60,527 Added 2.01%
3,064,445 $72.7 Million
Q3 2022

Oct 21, 2022
BUY
$16.58 - $27.9 $1.37 Million - $2.3 Million
82,440 Added 2.82%
3,003,918 $49.9 Million
Q2 2022

Jul 26, 2022
SELL
$15.45 - $29.52 $1.45 Million - $2.76 Million
-93,563 Reduced 3.1%
2,921,478 $58.1 Million
Q1 2022

Apr 27, 2022
SELL
$21.94 - $42.51 $2.33 Million - $4.51 Million
-106,062 Reduced 3.4%
3,015,041 $83.1 Million
Q4 2021

Feb 02, 2022
BUY
$36.09 - $53.79 $5.94 Million - $8.86 Million
164,724 Added 5.57%
3,121,103 $129 Million
Q3 2021

Oct 25, 2021
SELL
$35.62 - $52.97 $7.55 Million - $11.2 Million
-211,859 Reduced 6.69%
2,956,379 $137 Million
Q2 2021

Aug 02, 2021
SELL
$32.94 - $56.62 $3.01 Million - $5.17 Million
-91,284 Reduced 2.8%
3,168,238 $127 Million
Q1 2021

Apr 30, 2021
SELL
$44.47 - $81.38 $556,586 - $1.02 Million
-12,516 Reduced 0.38%
3,259,522 $175 Million
Q4 2020

Feb 05, 2021
BUY
$32.49 - $61.88 $9.38 Million - $17.9 Million
288,583 Added 9.67%
3,272,038 $160 Million
Q3 2020

Oct 30, 2020
SELL
$26.73 - $35.67 $4.32 Million - $5.77 Million
-161,731 Reduced 5.14%
2,983,455 $96.9 Million
Q2 2020

Jul 27, 2020
SELL
$19.49 - $28.11 $2.77 Million - $4 Million
-142,281 Reduced 4.33%
3,145,186 $81.5 Million
Q1 2020

Apr 27, 2020
BUY
$16.13 - $30.17 $3.78 Million - $7.07 Million
234,216 Added 7.67%
3,287,467 $79.9 Million
Q4 2019

Jan 31, 2020
BUY
$20.78 - $29.99 $6.01 Million - $8.67 Million
289,015 Added 10.46%
3,053,251 $85.2 Million
Q3 2019

Oct 31, 2019
BUY
$23.87 - $30.93 $39 Million - $50.5 Million
1,633,287 Added 144.42%
2,764,236 $66.3 Million
Q2 2019

Jul 29, 2019
BUY
$22.1 - $28.56 $11.8 Million - $15.3 Million
534,049 Added 89.47%
1,130,949 $32.2 Million
Q1 2019

May 08, 2019
BUY
$12.0 - $25.76 $7.16 Million - $15.4 Million
596,900 New
596,900 $14.9 Million

Others Institutions Holding VCYT

# of Institutions
339
Shares Held
76.3M
Call Options Held
212K
Put Options Held
18.5K
View Full List

About VERACYTE, INC.

VCYT Quotes by TradingView
  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.16B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email